What's in Ahn-Gook Pharmaceuticals Co.,Ltd's pipeline?

Ahn-Gook Pharmaceuticals Co.,Ltd has 31 drugs in our index: 1 marketed, 0 filed, 18 in Phase 3, 0 in Phase 2, 12 in Phase 1.

Which companies overlap with Ahn-Gook Pharmaceuticals Co.,Ltd's portfolio?

Top competitors by shared drug class: Pfizer, EMS, GlaxoSmithKline, Addpharma Inc., Merck Sharp & Dohme LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ahn-gook-pharmaceuticals-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Ahn-Gook Pharmaceuticals Co.,Ltd — Portfolio Competitive Intelligence Brief

Ahn-Gook Pharmaceuticals Co.,Ltd pipeline: 1 marketed, 0 filed, 18 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 18 Phase 3 0 Phase 2 12 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Carvedilol 25mg	Carvedilol 25mg	marketed
AGSCT101 12.5mg	AGSCT101 12.5mg	phase 3
AG2304T	AG2304T	phase 3	PD-1 inhibitor	PD-1	Oncology
AGU (Active Comparator)	AGU (Active Comparator)	phase 3
AGT4	AGT4	phase 3	Angiotensin II receptor antagonist	AT1 receptor	Cardiovascular
AGR tablet	AGR tablet	phase 3	small molecule	unknown	unknown
AG NPP709syrup	AG NPP709syrup	phase 3	ACE inhibitor	ACE	Cardiovascular
AGT2	AGT2	phase 3
AGT4, AGZ	AGT4, AGZ	phase 3	angiotensin II receptor blocker	AT1 receptor	Cardiovascular
AGSAVI	AGSAVI	phase 3
AGSPT201 Tab contains S-pantoprazole	AGSPT201 Tab contains S-pantoprazole	phase 3	Proton pump inhibitor (PPI)	H+/K+-ATPase (proton pump)	Gastroenterology
AG20011	AG20011	phase 3	PI3K inhibitor	PI3K	Oncology

Therapeutic area mix

Oncology · 4
Cardiovascular · 3
Gastroenterology · 1
Unknown · 1
unknown · 1
Infectious Diseases · 1
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 5 shared drug classes
EMS · 4 shared drug classes
GlaxoSmithKline · 4 shared drug classes
Addpharma Inc. · 4 shared drug classes
Merck Sharp & Dohme LLC · 4 shared drug classes
Jiangsu HengRui Medicine Co., Ltd. · 4 shared drug classes
Boryung Pharmaceutical Co., Ltd · 3 shared drug classes
Beijing Tiantan Hospital · 3 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Ahn-Gook Pharmaceuticals Co.,Ltd:

Cite this brief

Drug Landscape (2026). Ahn-Gook Pharmaceuticals Co.,Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ahn-gook-pharmaceuticals-co-ltd. Accessed 2026-05-16.